Results 41 to 50 of about 628,756 (329)

Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss

open access: yesActa ophthalmologica, 2019
To compare the structure and function of the Meibomian gland and eyelid blinking patterns between thyroid eye disease (TED) patients with dry eye and nonthyroidal dry eye (DE) patients.
Jinhwan Park, S. Baek
semanticscholar   +1 more source

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study [PDF]

open access: yes, 2019
Background: Dry eye disease (DED) affects more than 14% of the elderly population causing decrease of quality of life, high costs and vision impairment.
Allegretti, M.   +7 more
core   +1 more source

IRT5 Probiotics Changes Immune Modulatory Protein Expression in the Extraorbital Lacrimal Glands of an Autoimmune Dry Eye Mouse Model [PDF]

open access: yes, 2020
PURPOSE. While the association between the gut microbiome and the immune system has been studied in autoimmune disorders, little is known about ocular disease.
Choi, Se Hyun   +6 more
core   +1 more source

A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye [PDF]

open access: yes, 2017
Cyclosporine A (Cs) has been used as effective topical therapy for inflammatory dry eye disease since more than a decade. However, due to its lipophilic character, Cs is formulated as emulsions or oily solutions for topical application. This experimental
Maria Notara   +4 more
core   +1 more source

Impact of aging on the pathophysiology of dry eye disease: A systematic review and meta-analysis.

open access: yesThe ocular surface, 2022
PURPOSE Dry eye disease (DED) is a common age-related ocular surface disease. However, it is unknown how aging influences the ocular surface microenvironment.
Koji Kitazawa   +10 more
semanticscholar   +1 more source

Inflammation and dry eye disease-where are we?

open access: yesInternational Journal of Ophthalmology, 2022
The presence of inflammation in dry eye disease (DED) results in increased patient symptomatology, ocular surface damage and worsening tear dysfunction.
Srinivas K. Rao   +4 more
semanticscholar   +1 more source

Formulation Considerations for the Management of Dry Eye Disease

open access: yesPharmaceutics, 2021
Dry eye disease (DED) is one of the most common ocular surface disorders characterised by a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature involving several inter-related underlying pathologies, it can rapidly ...
Priyanka Agarwal, J. Craig, I. Rupenthal
semanticscholar   +1 more source

Advances in Dry Eye Disease Examination Techniques

open access: yesFrontiers in Medicine, 2022
Dry eye-related ocular surface examination is very important in the diagnosis and treatment of dry eye disease. With the recent advances in science and technology, dry eye examination techniques have progressed rapidly, which has greatly improved dry eye
Yaying Wu   +6 more
semanticscholar   +1 more source

The Interblink Interval in Normal and Dry Eye Subjects [PDF]

open access: yes, 2013
Purpose: Our aim was to extend the concept of blink patterns from average interblink interval (IBI) to other aspects of the distribution of IBI. We hypothesized that this more comprehensive approach would better discriminate between normal and dry eye ...
Abelson, Mark Barry   +4 more
core   +1 more source

Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan

open access: yesJAMA Network Open, 2022
Key Points Question Is the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors vs glucagonlike peptide-1 receptor agonists (GLP-1 RAs) associated with dry eye disease among adults with type 2 diabetes (T2D)?
Yu-Chen Su   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy